Business Description
Evome Medical Technologies Inc
NAICS : 423450
SIC : 3912
ISIN : CA45781J2074
Description
Evome Medical Technologies Inc is a medical device company. It is focused on human performance and rehabilitative solutions.
Financial Strength
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.06 | |||||
Equity-to-Asset | -0.06 | |||||
Debt-to-Equity | -7.97 | |||||
Debt-to-EBITDA | -1.62 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -2.82 | |||||
Beneish M-Score | -4.51 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 340 | |||||
3-Year EBITDA Growth Rate | -45.5 | |||||
3-Year EPS without NRI Growth Rate | -43.8 | |||||
3-Year FCF Growth Rate | -35.7 | |||||
3-Year Book Growth Rate | -43.8 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 66.13 | |||||
9-Day RSI | 61.77 | |||||
14-Day RSI | 60.03 | |||||
6-1 Month Momentum % | -53.85 | |||||
12-1 Month Momentum % | -53.85 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.55 | |||||
Quick Ratio | 0.26 | |||||
Cash Ratio | 0.03 | |||||
Days Inventory | 109.01 | |||||
Days Sales Outstanding | 50.19 | |||||
Days Payable | 63.73 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -33.2 | |||||
Shareholder Yield % | -49.35 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 34.58 | |||||
Operating Margin % | -10.57 | |||||
Net Margin % | -33.45 | |||||
FCF Margin % | 5.88 | |||||
ROE % | -264.76 | |||||
ROA % | -36.34 | |||||
ROIC % | -10.12 | |||||
3-Year ROIIC % | -8.67 | |||||
ROC (Joel Greenblatt) % | -124.14 | |||||
ROCE % | -115.93 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.23 | |||||
Price-to-Free-Cash-Flow | 3.95 | |||||
Price-to-Operating-Cash-Flow | 3.75 | |||||
EV-to-EBIT | -1.89 | |||||
EV-to-EBITDA | -2.57 | |||||
EV-to-Revenue | 0.53 | |||||
EV-to-Forward-Revenue | 0.39 | |||||
EV-to-FCF | 9.02 | |||||
Earnings Yield (Greenblatt) % | -52.91 | |||||
FCF Yield % | 27.46 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Evome Medical Technologies Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | 57.979 | ||
EPS (TTM) (C$) | -0.263 | ||
Beta | 1.33 | ||
Volatility % | 96.46 | ||
14-Day RSI | 60.03 | ||
14-Day ATR (C$) | 0.009576 | ||
20-Day SMA (C$) | 0.131 | ||
12-1 Month Momentum % | -53.85 | ||
52-Week Range (C$) | 0.08 - 0.3 | ||
Shares Outstanding (Mil) | 82.7 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Evome Medical Technologies Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Evome Medical Technologies Inc Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Evome Medical Technologies Inc Frequently Asked Questions
What is Evome Medical Technologies Inc(TSXV:EVMT)'s stock price today?
The current price of TSXV:EVMT is C$0.15. The 52 week high of TSXV:EVMT is C$0.30 and 52 week low is C$0.08.
When is next earnings date of Evome Medical Technologies Inc(TSXV:EVMT)?
The next earnings date of Evome Medical Technologies Inc(TSXV:EVMT) is .
Does Evome Medical Technologies Inc(TSXV:EVMT) pay dividends? If so, how much?
Evome Medical Technologies Inc(TSXV:EVMT) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |